Attention Deficit/Hyperactivity Disorder (ADHD - Adults) Clinical Trials

A listing of Attention Deficit/Hyperactivity Disorder (ADHD - Adults) medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Dothan Alabama 36303

A clinical trial to evaluate treatments using Dasotraline for patients with Attention Deficit Hyperactivity Disorder

Dothan Alabama 36303

Patients are needed to participate in a clinical research study of SHP465 and Placebo to evaluate Attention-Deficit Hyperactivity Disorder (ADHD)

Arizona

NoesisPharma,LLC
Phoenix Arizona 85032

A Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group, Efficacy and Safety Study of 2 Doses of Dasotraline in Adults with Attention Deficit Hyperactivity Disorder (ADHD)

Arkansas

Preferred Research Partners Inc.
Little Rock Arkansas 72211

A Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group, Efficacy and Safety Study of 2 Doses of Dasotraline in Adults with Attention Deficit Hyperactivity Disorder (ADHD)

View More ▼

Little Rock Arkansas 72202

A clinical study for patients using Ampicillin

California

Southern California Research LLC
Beverly Hills California 90210

A Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group, Efficacy and Safety Study of 2 Doses of Dasotraline in Adults with Attention Deficit Hyperactivity Disorder (ADHD)

Southern California Research, LLC
Beverly Hills California 90210

Interventional, Randomised, Double-blind, Placebo-controlled, Fixed-dose Study of Vortioxetine in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Pharmacology Research Institute, Encino
Encino California 91316

A clinical research study is testing an investigational ADHD medication for adults. This is A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465-306 in Adults Aged 18-55 Years with Attention-deficit/Hyperactivity Disorder (ADHD)

Pharmacology Research Institute
Encino California 91316

A Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group, Efficacy and Safety Study of 2 Doses of Dasotraline in Adults with Attention Deficit Hyperactivity Disorder (ADHD)

Collaborative Neuroscience Network, LLC
Garden Grove California 92845

A Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group, Efficacy and Safety Study of 2 Doses of Dasotraline in Adults with Attention Deficit Hyperactivity Disorder (ADHD)

Collaborative Neuroscience Network, LLC
Garden Grove California 92845

Interventional, Randomised, Double-blind, Placebo-controlled, Fixed-dose Study of Vortioxetine in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Pharmacology Research Institute, Los Alamitos
Los Alamitos California 90720

A clinical research study is testing an investigational ADHD medication for adults. This is A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465-306 in Adults Aged 18-55 Years with Attention-deficit/Hyperactivity Disorder (ADHD)

Synergy Clinical Research Center
National City California 91950

Interventional, Randomised, Double-blind, Placebo-controlled, Fixed-dose Study of Vortioxetine in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Pharmacology Research Institute, Newport Beach
Newport Beach California 92660

A clinical research study is testing an investigational ADHD medication for adults. This is A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Forced-dose Titration, Safety and Efficacy Study of SHP465-306 in Adults Aged 18-55 Years with Attention-deficit/Hyperactivity Disorder (ADHD)

AVIDA, Inc.
Newport Beach California 92660

Does your child struggle with ADHD symptoms in the morning?

North County Clinical Research
Oceanside California 92056

A Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group, Efficacy and Safety Study of 2 Doses of Dasotraline in Adults with Attention Deficit Hyperactivity Disorder (ADHD)

Elite Clinical Trials, Inc.
Wildomar California 92595

A Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group, Efficacy and Safety Study of 2 Doses of Dasotraline in Adults with Attention Deficit Hyperactivity Disorder (ADHD)

View More ▼

Beverly Hills California

A clinical trial to evaluate treatments using Vortioxetine 10 mg tablet, Vortioxetine 20 mg tablet and Placebo tablet for patients with Attention Deficit Hyperactivity Disorder (ADHD)

Culver City California 90230

A clinical trial to evaluate treatments using Dasotraline for patients with Attention Deficit Hyperactivity Disorder

Encino California 91316

A clinical research study of SHP465 12.5mg capsules (one capsule daily), Placebo and SHP465 12.5mg, 25mg, or 37.5mg capsules (one capsule daily) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD)

Garden Grove California

A clinical trial to evaluate treatments using Vortioxetine 10 mg tablet, Vortioxetine 20 mg tablet and Placebo tablet for patients with Attention Deficit Hyperactivity Disorder (ADHD)

La Jolla California 92093

A clinical study for patients using Ampicillin

Los Alamitos California 90720

A clinical research study of SHP465 12.5mg capsules (one capsule daily), Placebo and SHP465 12.5mg, 25mg, or 37.5mg capsules (one capsule daily) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD)

Los Angeles California 90095

A clinical study for patients using Ampicillin

Los Angeles California 90095

A clinical trial to evaluate treatments using Attentional Intelligence Method and Scrabble for patients with Attention Deficit Hyperactivity Disorder (ADHD)

Los Angeles California 90095

Patients are needed to participate in a clinical research study evaluating EMS 7500 Digital Muscle Stimulator for the treatment of Attention-Deficit/Hyperactivity Disorder

National City California

A clinical trial to evaluate treatments using Vortioxetine 10 mg tablet, Vortioxetine 20 mg tablet and Placebo tablet for patients with Attention Deficit Hyperactivity Disorder (ADHD)

Newport Beach California 92660

A clinical research study of SHP465 12.5mg capsules (one capsule daily), Placebo and SHP465 12.5mg, 25mg, or 37.5mg capsules (one capsule daily) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD)

Newport Beach California 92660

A Phase 2 clinical study for patients with Attention- Deficit/Hyperactivity Disorder

Orange California 92868

A clinical research study of SHP465 12.5mg capsules (one capsule daily), Placebo and SHP465 12.5mg, 25mg, or 37.5mg capsules (one capsule daily) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD)

Orange California 92868

Patients are needed to participate in a clinical research study of SHP465 and Placebo to evaluate Attention-Deficit Hyperactivity Disorder (ADHD)

Sacramento California 95817

A clinical research study of Lisdexamfetamine for the treatment of Attention Deficit Hyperactivity Disorder

San Diego California 92108

Patients are needed to participate in a clinical research study of SHP465 and Placebo to evaluate Attention-Deficit Hyperactivity Disorder (ADHD)

Spring Valley California 91978

Patients are needed to participate in a clinical research study of SHP465 and Placebo to evaluate Attention-Deficit Hyperactivity Disorder (ADHD)

Wildomar California 92595

A clinical research study of SHP465 12.5mg capsules (one capsule daily), Placebo and SHP465 12.5mg, 25mg, or 37.5mg capsules (one capsule daily) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD)

Wildomar California 92595

A clinical trial to evaluate treatments using Dasotraline for patients with Attention Deficit Hyperactivity Disorder

Wildomar California 92595

Patients are needed to participate in a clinical research study of SHP465 and Placebo to evaluate Attention-Deficit Hyperactivity Disorder (ADHD)

Colorado

MCB Clinical Research Centers, LLC
Colorado Springs Colorado 80910

A Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group, Efficacy and Safety Study of 2 Doses of Dasotraline in Adults with Attention Deficit Hyperactivity Disorder (ADHD)

View More ▼

Aurora Colorado 80045

A clinical study for patients using Ampicillin

Colorado Springs Colorado 80910

A clinical research study of SHP465 12.5mg capsules (one capsule daily), Placebo and SHP465 12.5mg, 25mg, or 37.5mg capsules (one capsule daily) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD)

Colorado Springs Colorado 80910

A clinical trial to evaluate treatments using Dasotraline for patients with Attention Deficit Hyperactivity Disorder

Colorado Springs Colorado 80910

Patients are needed to participate in a clinical research study of SHP465 and Placebo to evaluate Attention-Deficit Hyperactivity Disorder (ADHD)

Connecticut

Connecticut Clinical Research
Cromwell Connecticut 6416

A Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group, Efficacy and Safety Study of 2 Doses of Dasotraline in Adults with Attention Deficit Hyperactivity Disorder (ADHD)

View More ▼

New Haven Connecticut 06504

A clinical study for patients using Ampicillin

Delaware

Wilmington Delaware 19803

A clinical study for patients using Ampicillin

District of Columbia

Washington District of Columbia 20010

A clinical study for patients using Ampicillin

Florida

Florida Clinical Research Center, LLC
Bradenton Florida 34201

Does your child struggle with ADHD symptoms in the morning?

Florida Clinical Research Center, LLC
Bradenton Florida 34201

Interventional, Randomised, Double-blind, Placebo-controlled, Fixed-dose Study of Vortioxetine in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

CNS Clinical Research Group
Coral Springs Florida 33067

A Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group, Efficacy and Safety Study of 2 Doses of Dasotraline in Adults with Attention Deficit Hyperactivity Disorder (ADHD)

Gulfcoast Clinical Research
Fort Myers Florida 33912

A Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group, Efficacy and Safety Study of 2 Doses of Dasotraline in Adults with Attention Deficit Hyperactivity Disorder (ADHD)